Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naïve Patients in Chile.

by Constanza L Vargas, Manuel A Espinoza, Andrés Giglio, Alejandro Soza
Published 2015-01-01